The tetraamine chelator outperforms HYNIC in a new technetium-99m-labelled somatostatin receptor 2 antagonist

BACKGROUND: Somatostatin receptor targeting radiopeptides are successfully being used to image, stage, and monitor patients with neuroendocrine tumours. They are exclusively agonists that internalise upon binding to the relevant receptor. According to recent reports, antagonists may be preferable to...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:EJNMMI Res
Main Authors: Abiraj, Keelara, Ursillo, Samer, Tamma, Maria Luisa, Rylova, Svetlana N., Waser, Beatrice, Constable, Edwin C., Fani, Melpomeni, Nicolas, Guillaume P., Reubi, Jean Claude, Maecke, Helmut R.
Formato: Artigo
Idioma:Inglês
Publicado em: Springer Berlin Heidelberg 2018
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6070450/
https://ncbi.nlm.nih.gov/pubmed/30069789
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13550-018-0428-y
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados